Skip to main content
BHVN logo

BHVN · Biohaven Ltd. · Analyst Estimates

Track BHVN — free
$12.97 +0.10 (+0.78%) At close · Oct 5
Market Cap
$2.01B
Shares
151.04M
Volume · Oct 5 1.67M Avg daily vol (3M) 2.63M

Analyst Estimates

Compare analyst forecasts for Biohaven Ltd. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-05 09:12 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.88
-1.64914
-0.08958
—
-2.64272
-2.40876
-1.64914
-2.39501
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
0
1
1
Revenue
USD
Publication date not stated
0
50000000
350000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-2.62
-1.87193
-1.43413
—
-1.98697
-1.94398
-1.87193
-1.95022
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
0
2
1
Revenue
USD
Publication date not stated
0
39992400
163000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.73
0.16457
1.66
—
-0.64914
-0.57118
0.16457
-0.57278
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
0
1
1
Revenue
USD
Publication date not stated
0
50000000
350000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
14
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.67
-0.48559
-0.23202
—
-0.56633
-0.4939
-0.48559
-0.49017
— — — —
EPS
analysts
Publication date not stated
— — —
6
— — — —
2
1
1
0
Revenue
USD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
13
— — — — — — — —
Key facts CIK 1935979 CUSIP G1110E107 13F (30d) 7 filings 7 filers Visit website Investor relations